Ilsung Pharmaceuticals Co., Ltd. (003120.KS)

KRW 15970.0

(-0.19%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 419.18 Billion 494.42 Billion 371.38 Billion 371.22 Billion 369.51 Billion 347.26 Billion
Total Current Assets 293.94 Billion 343.9 Billion 279.96 Billion 263.24 Billion 272.44 Billion 279.42 Billion
Cash And Short Term Investments 235.42 Billion 299.93 Billion 64.08 Billion 45.24 Billion 51.96 Billion 53.91 Billion
Cash and Cash Equivalents 160.08 Billion 272.92 Billion 50.84 Billion 36.21 Billion 37.27 Billion 1.39 Billion
Short Term Investments 75.33 Billion 27.01 Billion 13.24 Billion 9.02 Billion 14.68 Billion 52.52 Billion
Net Receivables 24.79 Billion 23.33 Billion 203.37 Billion 204.82 Billion 206.2 Billion 209.78 Billion
Inventory 31.24 Billion 20.64 Billion 12.47 Billion 13.13 Billion 14.14 Billion 15.38 Billion
Other Current Assets 2.49 Billion 420.00 28.89 Million 41.7 Million 120.81 Million 336.4 Million
Total Non-Current Assets 125.24 Billion 150.51 Billion 91.41 Billion 107.97 Billion 97.07 Billion 67.84 Billion
Net PPE 69.75 Billion 92.64 Billion 33.11 Billion 26.03 Billion 24.11 Billion 25.67 Billion
Good Will And Intangible Assets 2.37 Billion 2.29 Billion 1.91 Billion 278.91 Million 303.24 Million 327.57 Million
Good Will - - - - - -
Intangible Assets 2.37 Billion 2.29 Billion 1.91 Billion 278.91 Million 303.24 Million 327.57 Million
Long-Term Investments 51.41 Billion 25.38 Billion 40.5 Billion 71.88 Billion 54.49 Billion -11.16 Billion
Tax Assets 5.09 Million - 15.88 Billion 9.77 Billion 18.17 Billion 53 Billion
Other Non Current Assets 1.7 Billion 30.18 Billion -320.00 300.00 -710.00 -480.00
Other Assets - - -100.00 - - -
Total Liabilities 36.43 Billion 48.85 Billion 25.47 Billion 23.74 Billion 24.02 Billion 22.92 Billion
Total Current Liabilities 34.89 Billion 42.55 Billion 20.72 Billion 16.82 Billion 18.31 Billion 15.9 Billion
Account Payables 5.76 Billion 5.05 Billion 758.27 Million 2.1 Billion 2.32 Billion 2.32 Billion
Tax Payables 204.47 Million 29.65 Billion 1.57 Billion 292.62 Million 3.15 Billion 1.75 Billion
Short Term Debt 118.44 Million 92.54 Million 171.54 Million 311.11 Million -9.45 Million -
Deferred Revenue 2 Million - 17.62 Billion 12.43 Billion 9.45 Million -
Other Current Liabilities 29 Billion 37.41 Billion 2.17 Billion 1.97 Billion 15.98 Billion 13.58 Billion
Total Non Current Liabilities 1.54 Billion 6.29 Billion 4.74 Billion 6.92 Billion 5.71 Billion 7.02 Billion
Long-Term Debt 119.67 Million 181.8 Million 9.51 Million 130.38 Million 126.5 Million -
Deferred Revenue Non Current 900.83 Million 1.13 Billion 1.37 Billion 1.52 Billion 404.93 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 523.62 Million - - 47.25 Million -10.00 994.38 Million
Other Liabilities - - - - - -
Total Equity 382.75 Billion 445.56 Billion 345.9 Billion 347.47 Billion 345.48 Billion 324.33 Billion
Stock Holders Equity 382.75 Billion 445.56 Billion 345.9 Billion 347.47 Billion 345.48 Billion 324.33 Billion
Common Stock 13.3 Billion 13.3 Billion 13.3 Billion 13.3 Billion 13.3 Billion 13.3 Billion
Retained Earnings 55.32 Billion 506.89 Billion 402.81 Billion 404.57 Billion 398.94 Billion 393.64 Billion
Accumulated other comprehensive income 403.7 Billion 400.79 Billion 402.87 Billion 400.55 Billion 395.65 Billion 408.39 Billion
Common Stock Equity 382.75 Billion 445.56 Billion 345.9 Billion 347.47 Billion 345.48 Billion 324.33 Billion
Capital Lease Obligation 119.67 Million 274.35 Million 181.06 Million 441.5 Million 126.5 Million -
Total Investments 126.74 Billion 52.39 Billion 53.74 Billion 80.91 Billion 69.17 Billion 41.35 Billion
Total Debt 238.12 Million 274.35 Million 181.06 Million 441.5 Million 126.5 Million -
Net Debt -159.84 Billion -272.64 Billion -50.66 Billion -35.77 Billion -37.15 Billion -1.39 Billion

Balance Sheet Charts